Surgical enucleation for the treatment of renal tumors.
BACKGROUND
We analyzed our institutional experience with surgical enucleation for the primary treatment of small renal tumors.


METHODS
Patient demographics, histological features, effect of different types of vascular control and outcome from surgery were analyzed in 45 patients. A majority of the tumors (67%) were diagnosed incidentally.


RESULTS
All were stage T(1), 77% were low grade (I-II) and 23% were high grade (III-IV). Complication occurred in 12% of patients. At a mean follow-up of 34 months (range 7-97), 28 of 33 patients (84%) with malignant tumors were alive without evidence of disease. One patient with a solitary kidney developed recurrent tumor after enucleation that required nephrectomy. Mean operative time was significantly lower with the compression technique versus direct vascular control (164 +/- 12 min vs. 233 +/- 15 min, p = 0.002). There were no differences in outcome between the two techniques.


CONCLUSIONS
Surgical enucleation is a safe and viable procedure for the treatment of small renal tumors. Manual compression of the kidney appears to be at least as effective as clamping of the renal vessels in obtaining vascular control during the procedure and is more expeditious.
Franks
Michael E
ME
Department of Urology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Hrebinko
Ronald L
RL
Konety
Badrinath R
BR
D018249:Adenoma, Oxyphilic / Q000401:mortality / Q000601:surgery; D002292:Carcinoma, Renal Cell / Q000401:mortality / Q000601:surgery; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007680:Kidney Neoplasms / Q000401:mortality / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D016019:Survival Analysis; D013997:Time Factors